Android Apple

BridgeBio Pharma, Inc. (BBIO) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$26.49

north_east $0.28 (1.07%)
Day's range
$26.02
Day's range
$26.9

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/24/2024 Citigroup David Lebowitz $45.00 $24.17   86.18%
10/17/2024 Leerink Partners Mani Foroohar $46.00 $26.34   74.64%
09/11/2024 Piper Sandler Biren Amin $46.00 $28.78   59.83%
09/03/2024 Mizuho Securities Salim Syed $53.00 $29.92   77.14%
06/24/2024 Raymond James Danielle Brill $46.00 $22.65   103.14%
06/05/2024 BMO Capital Kostas Biliouris $37.00 $26.93   37.42%
06/05/2024 Wells Fargo Tiago Fauth $58.00 $27.13   113.79%
05/30/2024 Goldman Sachs Paul Choi $50.00 $27.61   81.09%
05/28/2024 UBS Eliana Merle $47.00 $27.94   68.22%
05/20/2024 H.C. Wainwright Raghuram Selvaraju $43.00 $30.09   42.9%
05/13/2024 Evercore ISI Cory Kasimov $50.00 $28.50   75.44%

BridgeBio Pharma, Inc. FAQ's

What analysts cover BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. has been rated by research analysts at Citigroup, Leerink Partners, Piper Sandler, Mizuho Securities, Raymond James, BMO Capital in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.